NMTC
Income statement / Annual
Last year (2023), NeuroOne Medical Technologies Corporation's total revenue was $1.95 M,
an increase of 1,040.65% from the previous year.
In 2023, NeuroOne Medical Technologies Corporation's net income was -$11.86 M.
See NeuroOne Medical Technologies Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$1.95 M
|
$171,169.00
|
$178,146.00
|
$1.93 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$742.00
|
$773.00
|
| Cost of Revenue |
$1.50 M |
$241,963.00 |
$275,895.00 |
$1.86 M |
$27,569.00 |
$21,667.00 |
$17,633.00 |
$7,740.00 |
$0.00 |
$0.00 |
| Gross Profit |
$456,517.00 |
-$70,794.00 |
-$97,749.00 |
$63,116.00 |
-$27,569.00 |
-$21,667.00 |
-$17,633.00 |
-$7,740.00 |
$742.00 |
$773.00 |
| Gross Profit Ratio |
0.23 |
-0.41 |
-0.55 |
0.03 |
0 |
0 |
0 |
0 |
1 |
1 |
| Research and Development
Expenses |
$6.94 M
|
$4.93 M
|
$3.93 M
|
$2.08 M
|
$1.53 M
|
$951,064.00
|
$735,333.00
|
$0.00
|
$2,400.00
|
$0.00
|
| General & Administrative
Expenses |
$6.75 M
|
$6.71 M
|
$6.26 M
|
$4.75 M
|
$4.28 M
|
$3.22 M
|
$2.34 M
|
$189,324.00
|
$7,936.00
|
$0.00
|
| Selling & Marketing
Expenses |
$173,430.00
|
$270,612.00
|
$338,837.00
|
$0.00
|
$0.00
|
$322,841.00
|
$0.00
|
-$156,713.00
|
$22,979.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$6.93 M
|
$6.98 M
|
$6.26 M
|
$4.75 M
|
$4.28 M
|
$3.54 M
|
$2.34 M
|
$32,611.00
|
$30,915.00
|
$36,687.00
|
| Other Expenses |
$0.00 |
$31,152.00 |
$271,122.00 |
$0.00 |
$0.00 |
$1.30 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$12.41 M |
$9.96 M |
$10.12 M |
$4.90 M |
$5.81 M |
$3.19 M |
$3.07 M |
$32,611.00 |
$30,915.00 |
$36,687.00 |
| Cost And Expenses |
$13.91 M |
$10.20 M |
$10.40 M |
$4.90 M |
$5.81 M |
$3.21 M |
$3.07 M |
$32,611.00 |
$30,915.00 |
$36,687.00 |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$3,053.00 |
$7.52 M |
$284,557.00 |
$0.00 |
$1.40 M |
$0.00 |
$14,018.00 |
$330.00 |
| Depreciation &
Amortization |
$199,266.00
|
$226,213.00
|
$147,130.00
|
$70,552.00
|
$27,569.00
|
$21,667.00
|
$17,633.00
|
$7,740.00
|
$7,765.00
|
$0.00
|
| EBITDA |
-$11.76 M
|
-$9.91 M
|
-$9.80 M
|
-$4.85 M
|
-$5.79 M
|
-$4.15 M
|
-$3.05 M
|
-$32,611.00
|
-$30,915.00
|
-$35,914.00
|
| EBITDA Ratio |
-6.02 |
-57.91 |
-55.38 |
-2.52 |
0 |
0 |
0 |
0 |
-41.66 |
-46.46 |
| Operating Income Ratio
|
-6.12
|
-58.6
|
-57.36
|
-2.54
|
0
|
0
|
0
|
0
|
-41.66
|
-46.46
|
| Total Other
Income/Expenses Net |
$95,759.00
|
$31,152.00
|
$270,043.00
|
-$8.74 M
|
-$967,767.00
|
-$2.66 M
|
-$1.99 M
|
$156,713.00
|
$0.00
|
-$330.00
|
| Income Before Tax |
-$11.86 M |
-$10.00 M |
-$9.95 M |
-$13.64 M |
-$6.78 M |
-$6.83 M |
-$5.06 M |
-$32,611.00 |
-$30,915.00 |
-$36,244.00 |
| Income Before Tax Ratio
|
-6.07
|
-58.42
|
-55.84
|
-7.08
|
0
|
0
|
0
|
0
|
-41.66
|
-46.89
|
| Income Tax Expense |
$0.00 |
-$109,865.00 |
$274,175.00 |
$7.52 M |
$284,557.00 |
$3.00 |
$1.40 M |
$15,164.00 |
$31,948.00 |
$0.00 |
| Net Income |
-$11.86 M |
-$10.00 M |
-$9.95 M |
-$13.64 M |
-$6.78 M |
-$6.83 M |
-$5.06 M |
-$47,775.00 |
-$62,863.00 |
-$36,244.00 |
| Net Income Ratio |
-6.07 |
-58.42 |
-55.84 |
-7.08 |
0 |
0 |
0 |
0 |
-84.72 |
-46.89 |
| EPS |
-0.65 |
-0.63 |
-0.93 |
-2.52 |
-1.72 |
-2.43 |
-2.3 |
-0.0283 |
-0.0372 |
-0.0214 |
| EPS Diluted |
-0.65 |
-0.63 |
-0.93 |
-2.52 |
-1.72 |
-2.43 |
-2.3 |
-0.0283 |
-0.0372 |
-0.0214 |
| Weighted Average Shares
Out |
$18.12 M
|
$16.00 M
|
$10.70 M
|
$5.42 M
|
$3.95 M
|
$2.81 M
|
$2.20 M
|
$1.69 M
|
$1.69 M
|
$1.69 M
|
| Weighted Average Shares
Out Diluted |
$18.12 M
|
$16.00 M
|
$10.70 M
|
$5.42 M
|
$3.95 M
|
$2.81 M
|
$2.20 M
|
$1.69 M
|
$1.69 M
|
$1.69 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
